FIELD: pharmacology.
SUBSTANCE: there is produced synthetic derivative of phthalyl-glycyl-agginyl-piperidide peptide expressing anticoagulant activity estimated by inhibiting amidolytic thrombin activity in system in vitro and double prolongation of rats' blood plasma coagulation as compared with the control values in tests activated partial thromboplastin and thrombin time tests and having formula 
1, including pharmaceutically acceptable salts.
EFFECT: new synthetic peptide derivative expressing anticoagulant activity.
1 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIRECT THROMBIN INHIBITOR, POSSESSING ANTIPROLIFERATIVE ACTION | 2007 |
|
RU2369615C2 |
| MODIFIED DNA APTAMERS INHIBITING THROMBIN ACTIVITY | 2009 |
|
RU2410432C1 |
| ANTITHROMBOTIC COMPOSITION ON BASIS OF HEPARIN FOR PERORAL APPLICATION | 2008 |
|
RU2359681C1 |
| PREPARATION OF ANTICOAGULANT ACTION AND METHOD FOR ITS OBTAINING | 2006 |
|
RU2302250C1 |
| ANTICOAGULANT DRUG, WHICH IS A SYNTHETIC DIPEPTIDE Ac-Trp-Arg-Pip·HCl, A PHARMACEUTICAL COMPOSITION COMPRISING SAID ANTICOAGULANT DRUG | 2019 |
|
RU2712194C1 |
| APTAMER OLIGONUCLEOTIDE - DIRECT THROMBIN INHIBITOR | 2008 |
|
RU2401306C2 |
| DOSAGE FORM OF DNA-APTAMER | 2019 |
|
RU2730000C1 |
| USING TETRAPEPTIDE Arg-Pro-Gly-Pro AS AGENT FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, METHOD FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA, PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING HYPERCHOLESTEREMIA AND METHOD FOR PREPARING IT | 2013 |
|
RU2538801C2 |
| ANTICOAGULATING BIOLOGICALLY ACTIVE COMPLEX MADE OF SIBERIAN CEDAR BARK | 2007 |
|
RU2366441C2 |
| ANTITHROMBOTIC AGENT OF SIBERIAN FIR CELLULOSE | 2014 |
|
RU2571555C1 |
